Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

Palo Alto comes across in this incident as clueless, disingenuous, or both.

Let me sum this up:

* We believe Momenta will be the sole lovenox generic for the foreseeable future.

* Momenta has repeatedly said that expenses will stay relatively constant with minor increases.

* Momenta will not move the major portion of the FOB program or M118 forward without a partner.

* We believe Momenta will become the sole copaxone generic in the future.

Momenta now has an abundance of cash and will continue to add to it on a quarterly basis so why wouldn't this be a appropriate time for a buyback? Let's ask ourselves if Momenta purchasing its own stock wouldn't be a better long term investment than government paper at this time.

Palo Alto invested in Momenta for one reason and that's a return on their investment (3.5 million shares). Evidently, at this point Palo Alto must have the impression that Momenta is not using its capital appropriately or in the best interests of the stockholders.